NCT01007968View on ClinicalTrials.gov

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

LBH589

Trial Locations (6)

9007

Novartis Investigative Site, Sankt Gallen

84103

University of Utah / Huntsman Cancer Institute, Salt Lake City

2300 RC

Novartis Investigative Site, Leiden

SE-221 85

Novartis Investigative Site, Lund

SE-171 76

Novartis Investigative Site, Stockholm

EH4 2XR

Novartis Investigative Site, Edinburgh

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY